🇺🇸 FDA
Patent

US 7696338

Immunotoxin fusion proteins and means for expression thereof

granted A61KA61K47/6829A61K47/6849

Quick answer

US patent 7696338 (Immunotoxin fusion proteins and means for expression thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K47/6829, A61K47/6849